Paulson, Loeb, Viking Suffer As Allergan-Pfizer Merger Falls ThroughVW Staff
Allergan's stock nosedived on Monday, falling more than 20% as soon as the U.S Treasury announced its decision to pursue stricter rules to curb tax inversion mergers and buyouts. The Dublin-based pharmaceutical company was set to merge with U.S.-based Pfizer Inc. The Treasury's announcement on Monday broke down the $160 billion AGN-PFE merger which was set to make the world's largest pharmaceutical company, had it happened . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.